TP53 and hepatocellular carcinoma: Using RNA interference to reactivate p53 briefly in the p53-dificient mouse liver carcinoma model, (Xue et al., 2007) found that tumor proliferation is restricted and dependent on the cellular senescence program and consequently increased inflammation cytokines.